Latest news with #Yazen
South Wales Argus
10-07-2025
- Health
- South Wales Argus
Mounjaro sales banned from being advertised by watchdog
The Advertising Standards Authority (ASA) said the nine rulings against the ads – one featuring reality TV personality Gemma Collins – made it 'crystal clear' that all injectable forms of weight-loss medication were prescription-only and therefore banned from being advertised to the public. The ASA said the rulings established that the advertising of named weight-loss drugs such as Wegovy, Mounjaro, Ozempic and Saxenda was banned, as was the use of various claims such as 'obesity treatment jab' and 'weight loss pen'. In December, the ASA warned businesses and individuals who were targeting members of the public with ads for the medicines. We've banned ads from nine advertisers for illegally promoting weight-loss prescription-only medicines (POMs) to the public — breaching both the law and the ad rules. 🎥 Watch to find out what this means for advertisers. — ASA (@ASA_UK) July 9, 2025 It said no-one operating in the industry could say they had not been warned that weight-loss prescription-only medicines 'must not be promoted to the public'. The ads banned this week include an Instagram post by Collins, posted on January 6, which promoted the weight-loss service Yazen. In a video, Collins stated: 'I'm starting this year two sizes down, thanks to Yazen's weight loss app and medication. It's really quick and easy to get started with Yazen, it has absolutely changed my life… I finally found something that actually I lose weight on.' She continued: 'Yes, there's, you know, reports and stuff. And I'm not telling anyone to go on this medication, but it is prescribed on the NHS.' Two complainants challenged whether the ad breached rules because it promoted prescription-only medication to the public. Yazen said the post had been intended to share information about their 'holistic, responsible approach to weight loss', and had not been intended to focus solely on medication. Following notification of the complaint, and in agreement with Collins, the post has been amended to remove any reference to prescription-only medications. Yazen said they would ensure that future posts were compliant with the advertising code. Collins said she took her responsibilities under the advertising code seriously and strove to comply with them. She accepted that her posts had promoted the Yazen weight-loss service and app, and said Yazen would approve any marketing materials she might post in future, and she would follow any guidance that the ASA provided. The ASA also banned an ad for prescription-only weight-loss medication posted by CheqUp, which read: 'No GP or pharmacy visit, just a 2-minute online consultation.' CheqUp told the ASA that they believed the ad had been created in line with what had become widespread industry practice in the weight-loss sector. They assured the ASA that the ad would not appear again. Other providers who have had their ads banned include Juniper UK, Cloud Pharmacy, and Phlo Clinic and SemaPen. In April, the ASA said a search in January found around 1,800 unique paid-for weight-loss ads which were identified as potentially advertising a prescription-only medicine. It has published a joint Enforcement Notice with the Medicines and Healthcare products Regulatory Agency and General Pharmaceutical Council, making clear that ads for named weight-loss prescription-only medications are prohibited, including online, on social media and by influencers. Losing weight for a holiday is the biggest motivator for misusing Mounjaro for rapid results, says new research This comes as obesity experts at Chemist4U found that despite Mounjaro and other weight loss medications being designed and prescribed as a long term solution for obesity, more than one in four (28.6%), equivalent to 15 million Brits (15,784,439), would consider using weight loss medications to slim down just for a special occasion. Jason Murphy, Head of Pharmacy at Chemist4U says: 'Despite 55% of respondents to our survey rejecting weight loss injections as a short-term solution, our survey highlights a worrying attitude towards a medication that is designed as a long-term solution to obesity. Recommended reading: 'These prescription-only treatments, like Mounjaro, are designed for people living with obesity or weight-related health conditions and work best when used as part of a sustainable medically supervised plan, involving nutrition and physical activity. 'Changing your relationship with food from unhealthy to healthy takes time. If you abuse medications like Mounjaro for a short-term win, the likelihood is you'll put all the weight back on and become an unhealthy weight again very quickly after you stop taking the medication. 'Working with your prescriber and health care professionals to give yourself enough time to form healthy food habits is the best way to incorporate these injections into your sustainable weight loss journey.'
Leader Live
09-07-2025
- Health
- Leader Live
Mounjaro sales banned from being advertised by watchdog
The Advertising Standards Authority (ASA) said the nine rulings against the ads – one featuring reality TV personality Gemma Collins – made it 'crystal clear' that all injectable forms of weight-loss medication were prescription-only and therefore banned from being advertised to the public. The ASA said the rulings established that the advertising of named weight-loss drugs such as Wegovy, Mounjaro, Ozempic and Saxenda was banned, as was the use of various claims such as 'obesity treatment jab' and 'weight loss pen'. In December, the ASA warned businesses and individuals who were targeting members of the public with ads for the medicines. We've banned ads from nine advertisers for illegally promoting weight-loss prescription-only medicines (POMs) to the public — breaching both the law and the ad rules. 🎥 Watch to find out what this means for advertisers. It said no-one operating in the industry could say they had not been warned that weight-loss prescription-only medicines 'must not be promoted to the public'. The ads banned this week include an Instagram post by Collins, posted on January 6, which promoted the weight-loss service Yazen. In a video, Collins stated: 'I'm starting this year two sizes down, thanks to Yazen's weight loss app and medication. It's really quick and easy to get started with Yazen, it has absolutely changed my life… I finally found something that actually I lose weight on.' She continued: 'Yes, there's, you know, reports and stuff. And I'm not telling anyone to go on this medication, but it is prescribed on the NHS.' Two complainants challenged whether the ad breached rules because it promoted prescription-only medication to the public. Yazen said the post had been intended to share information about their 'holistic, responsible approach to weight loss', and had not been intended to focus solely on medication. Following notification of the complaint, and in agreement with Collins, the post has been amended to remove any reference to prescription-only medications. Yazen said they would ensure that future posts were compliant with the advertising code. Great as always to talk about #mounjaro on the @BBCBreakfast sofa with @BenThompsonTV @sallynugent #weightloss #nhs #GP@rcgp @WilmslowHealth @TheBMA Collins said she took her responsibilities under the advertising code seriously and strove to comply with them. She accepted that her posts had promoted the Yazen weight-loss service and app, and said Yazen would approve any marketing materials she might post in future, and she would follow any guidance that the ASA provided. The ASA also banned an ad for prescription-only weight-loss medication posted by CheqUp, which read: 'No GP or pharmacy visit, just a 2-minute online consultation.' CheqUp told the ASA that they believed the ad had been created in line with what had become widespread industry practice in the weight-loss sector. They assured the ASA that the ad would not appear again. Great as always to talk about #mounjaro on the @BBCBreakfast sofa with @BenThompsonTV @sallynugent #weightloss #nhs #GP@rcgp @WilmslowHealth @TheBMA Other providers who have had their ads banned include Juniper UK, Cloud Pharmacy, and Phlo Clinic and SemaPen. In April, the ASA said a search in January found around 1,800 unique paid-for weight-loss ads which were identified as potentially advertising a prescription-only medicine. It has published a joint Enforcement Notice with the Medicines and Healthcare products Regulatory Agency and General Pharmaceutical Council, making clear that ads for named weight-loss prescription-only medications are prohibited, including online, on social media and by influencers. This comes as obesity experts at Chemist4U found that despite Mounjaro and other weight loss medications being designed and prescribed as a long term solution for obesity, more than one in four (28.6%), equivalent to 15 million Brits (15,784,439), would consider using weight loss medications to slim down just for a special occasion. Jason Murphy, Head of Pharmacy at Chemist4U says: 'Despite 55% of respondents to our survey rejecting weight loss injections as a short-term solution, our survey highlights a worrying attitude towards a medication that is designed as a long-term solution to obesity. Recommended reading: 'These prescription-only treatments, like Mounjaro, are designed for people living with obesity or weight-related health conditions and work best when used as part of a sustainable medically supervised plan, involving nutrition and physical activity. 'Changing your relationship with food from unhealthy to healthy takes time. If you abuse medications like Mounjaro for a short-term win, the likelihood is you'll put all the weight back on and become an unhealthy weight again very quickly after you stop taking the medication. 'Working with your prescriber and health care professionals to give yourself enough time to form healthy food habits is the best way to incorporate these injections into your sustainable weight loss journey.'
Graziadaily
09-07-2025
- Health
- Graziadaily
Gemma Collins' weight loss Instagram ad banned for a surprising reason
An Instagram advert from The Only Way Is Essex star Gemma Collins promoting weight-loss drugs has been banned by the advertising watchdog. It follows nine other similar ads taken down by the Advertising Standards Authority (ASA). It is illegal to sell prescription-only medications to the public, including on social media. The ASA confirmed that all injectable weight-loss medications were prescription only, so it's illegal to promote them. The now banned post included Collins' video where she said, 'I'm starting this year two sizes down, thanks to Yazen's weight-loss app and medication'. She went on, 'I'm not telling anyone to go on this medication, but it is prescribed on the NHS.' Collins shared the post on 6 January, and promoted the weight-loss service Yazen, a Swedish digital healthcare brand that provides a doctor-supervised weight-loss programme using prescription medication along with coaching. Yazen said the post was supposed to share details about their holistic, responsible approach to weight-loss' and not just medication. The post has now been changed to remove any reference to prescription-only medications, and Collins agreed to follow ASA guidance in future. The ASA also banned an ad by CheqUp for weight-loss medication which read, 'No GP or pharmacy visit, just a 2-minute online consultation.' The ASA said the rulings confirmed that advertising named weight-loss drugs like Ozempic, Wegovy and Mounjaro is banned, along with using terms and claims like 'obesity treatment jab' and 'weight-loss pen'. The move follows increasing numbers of celebrities sharing that they use weight-loss drugs. In January of this year, Oprah Winfrey admitted to using an unnamed weight-loss drug to manage her weight and says doing so has changed her perception of thin people. Prior to taking the drug, Winfrey says she thought thin people had 'more willpower'. 'One of the things that I realised the very first time I took a GLP-1 was that all these years I thought that thin people had more willpower,' she said on her Oprah Winfrey podcast. 'They ate better foods. They were able to stick to it longer. They never had a potato chip. 'I realised the very first time I took the GLP-1 that they're not even thinking about it. They're eating when they're hungry and they're stopping when they're full.' Ruchira Sharma is Acting Senior Editor at Grazia, where she writes and edits features for print and digital. From online dating culture, to cryptocurrency and online conspiracy theories, she's most interested by how online life shapes society, and co-hosts the pop culture podcast Everything Is Content.
Daily Record
09-07-2025
- Health
- Daily Record
The rules of promoting weight loss jabs as Gemma Collins' Instagram post banned
The star was forced to delete an Instagram post where she had recommended a weight loss jab and app. TV personality Gemma Collins has been forced to remove a post from her Instagram profile where she had recommended a weight loss jab and app back in January. It comes as the Advertising Standards Authority (ASA) cracks down on the promotion of prescription-only weight loss medication. The star had said in her now-deleted post: "I'm starting this year two sizes down, thanks to Yazen's weight loss app and medication... I'm not telling anyone to go on this medication, but it is prescribed on the NHS." Yazen, the company Collins was promoting, is a Swedish digital healthcare brand. Users receive a doctor-supervised weight-loss programme that combines prescription medications with lifestyle coaching. Although Collins had not named a specific weight loss drug or specifically told people to take it, the ASA deemed the post as a breach of their rules that make the promotion of prescription weight loss medication illegal, reports the BBC. Eight other adverts were banned in this recent ASA crackdown. Weight loss jabs have soared in popularity in the UK recently, with around 1.5 million Brits currently taking them after the recent roll out of Mounjaro on the NHS. But what are the rules and regulations of promoting them? Here's everything you need to know about the ASA's rules for advertising weight loss meds and why Gemma Collins' post was banned. The ASA's rules for promoting weight loss medication Gemma Collins' post, as well as the eight other weight loss adverts that are now banned, were found by the ASA to breach the following set of rules. Prescription-only medicines cannot be advertised to the public Any medication that is prescription-only, including weight loss jabs, cannot be advertised via leaflets, press ads, posters or even sponsored ads. This rule extends to social media posts, such as the one posted by Gemma Collins. Advertisers cannot claim customers can achieve a specific rate of weight loss Gemma had claimed that she was 'two sizes down' thanks to the weight loss jabs. This rule states that promotional content for weight loss meds may not claim that people will lose a certain amount of weight in a certain amount of time. The ASA ruled against an ad by Skinny Revolution Ltd in 2020 because it included the claim 'LOSE OVER A FULL STONE IN JUST 2-4 WEEKS". Adverts can't feature health professionals or celebrities While Gemma's post did not feature a health professional, she herself is a celebrity who was deliberately promoting the weight loss drugs. This isn't the first time Collins has run into trouble with the ASA, as back in 2020 she posted similar social media posts that 'made direct and indirect references to a prescription-only weight loss product' The ASA considered this to be a prohibited endorsement of a medicine by a celebrity. Don't use before and after photographs Using before and after photographs to promote a weight loss product is likely to be picked up by the ASA as an advertising claim. The use of before and after images may only be acceptable if they are clearly attributed to a product that is not prescription-only. The eight other adverts banned by the ASA would have breached one or more of these rules, unjustly promoting prescription-only weight loss jabs to the public. Join the Daily Record WhatsApp community! Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile, select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'.
The Independent
09-07-2025
- Health
- The Independent
Gemma Collins's weight loss jab Instagram ad banned by watchdog
prescription -only weight-loss jabs have been banned by a watchdog. The Advertising Standards Authority (ASA) ruled against the ads, making it 'crystal clear' that all injectable forms of weight-loss medication were prescription-only and therefore could not advertised to the public. The crackdown has seen a total of nine rulings against the adverts, including one featuring TV personality Gemma Collins. In December, the ASA warned businesses and individuals who were targeting members of the public with ads for the medicines. It said no one operating in the industry could say they had not been warned that weight-loss prescription-only medicines 'must not be promoted to the public'. The ads banned this week include an Instagram post by Collins, posted on January 6, which promoted the weight-loss service Yazen. In a video, Collins said: 'I'm starting this year two sizes down, thanks to Yazen's weight loss app and medication. It's really quick and easy to get started with Yazen, it has absolutely changed my life… I finally found something that actually I lose weight on.' She added: 'Yes, there's reports and stuff. And I'm not telling anyone to go on this medication, but it is prescribed on the NHS.' Two complainants challenged whether the ad breached rules because it promoted prescription-only medication to the public. Yazen said the post had been intended to share information about their 'holistic, responsible approach to weight loss', and had not been intended to focus solely on medication. Following notification of the complaint, and in agreement with Collins, the post has been amended to remove any reference to prescription-only medications. Yazen said they would ensure that future posts were compliant with the advertising code. Collins said she took her responsibilities under the advertising code seriously and strove to comply with them. She accepted that her posts had promoted the Yazen weight-loss service and app, and said Yazen would approve any marketing materials she might post in future, and she would follow any guidance that the ASA provided. The ASA also banned an ad for prescription-only weight-loss medication posted by CheqUp, which read: 'No GP or pharmacy visit, just a 2-minute online consultation.' CheqUp told the ASA that they believed the ad had been created in line with what had become widespread industry practice in the weight-loss sector. They assured the ASA that the ad would not appear again. Other providers who have had their ads banned include Juniper UK, Cloud Pharmacy, and Phlo Clinic and SemaPen. The ASA said the rulings established the advertising of named weight-loss drugs such as Wegovy, Mounjaro, Ozempic and Saxenda was banned, as was the use of various claims such as 'obesity treatment jab' and 'weight loss pen'. In April, the ASA said a search in January found around 1,800 unique paid-for weight-loss ads which were identified as potentially advertising a prescription-only medicine. It has published a joint Enforcement Notice with the Medicines and Healthcare Products Regulatory Agency and General Pharmaceutical Council, making clear that ads for named weight-loss prescription-only medications are prohibited, including online, on social media and by influencers.
